United States Healthcare Equipment & Supplies

ICU Medical Inc (ICUI)

Track

ICU Medical Inc. experienced significant insider selling over the past ninety days, totaling approximately 882,242 dollars in net value. Six distinct transactions occurred, all involving divestments by executives and directors. This activity follows a period where the stock price appreciated by 48 percent, coinciding with a positive earnings report.
Ticker: ICUI Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for ICU Medical Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Sale 11 Aug 2026
Value US$756,635.99 | Price 169.01 | Shares 22,884 (+41.8%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-11 2026-08-11 S Sale
3.3
FINNEY ELISHA W
Non-Executive Director
22,884 +41.8%
169.01
US$756,636 		22,884 +41.8% 169.01 US$756,636
2026-08-11 2026-08-11 PrS Proposed sale
3.3
CHRISTIAN VOIGTLANDER

Officer

Officer
19,642
273.41
US$3,170,958 		19,642 273.41 US$3,170,958
2026-08-11 2026-08-11 PrS Proposed sale
3.3
ELISHA W FINNEY

Director

Non-Executive Director
55,494
401.12
US$4,132,457 		55,494 401.12 US$4,132,457
2026-08-11 2026-08-11 PrS Proposed sale
3.3
ELISHA W FINNEY

Director

Non-Executive Director
1,000
182.48
US$100,000 		1,000 182.48 US$100,000
2026-05-22 2026-05-22 PrS Proposed sale
2.9
DANIEL WOOLSON

Officer

Officer
2,123
132.21
US$280,685 		2,123 132.21 US$280,685
2026-05-22 2026-05-22 S Sale
2.9
Woolson Daniel

President

Officer
2,123 -8.6%
132.21
US$280,685 		2,123 -8.6% 132.21 US$280,685
2026-05-15 2026-05-14 S Sale
2.6
Sanzone Virginia Ruth

VP, General Counsel

Officer
2,447 -11.2%
124.08
US$303,624 		2,447 -11.2% 124.08 US$303,624
2026-05-14 2026-05-14 PrS Proposed sale
2.6
VIRGINIA SANZONE

Officer

Officer
2,447
124.08
US$303,624 		2,447 124.08 US$303,624
2026-05-13 2026-05-12 S Sale
2.2
Greenberg David C.
Non-Executive Director
2,424 -23.3%
122.91
US$297,934 		2,424 -23.3% 122.91 US$297,934
2026-05-12 2026-05-12 PrS Proposed sale
2.2
DAVID C GREENBERG

Director

Non-Executive Director
2,424
122.91
US$297,934 		2,424 122.91 US$297,934
2025-11-25 2025-11-25 PrS Proposed sale
2.9
DANIEL WOOLSON

Officer

Officer
2,897
152.35
US$441,364 		2,897 152.35 US$441,364
2025-11-25 2025-11-25 S Sale
2.9
Woolson Daniel

VP, GM-Infusion Capital

Officer
2,897 -20.4%
152.35
US$441,364 		2,897 -20.4% 152.35 US$441,364
2025-11-12 2025-11-11 PrS Proposed sale
2.6
VIRGINIA SANZONE

Officer

Officer
930
142.35
US$132,381 		930 142.35 US$132,381
2025-11-12 2025-11-11 PrS Proposed sale
3.3
ELISHA W FINNEY

Director

Non-Executive Director
1,285
140.42
US$180,440 		1,285 140.42 US$180,440
2025-11-12 2025-11-11 S Sale
2.6
Sanzone Virginia Ruth

VP, General Counsel

Officer
930 -14.6%
142.35
US$132,381 		930 -14.6% 142.35 US$132,381
2025-11-12 2025-11-11 S Sale
3.3
FINNEY ELISHA W
Non-Executive Director
1,285 -24.3%
140.42
US$180,440 		1,285 -24.3% 140.42 US$180,440
2025-08-27 2025-08-27 B Purchase
2.2
Greenberg David C.
Non-Executive Director
598 +8.1%
126.69
US$75,760 		598 +8.1% 126.69 US$75,760
2025-08-27 2025-08-27 B Purchase
2.2
Greenberg David C.
Non-Executive Director
602 +8.9%
126.14
US$75,938 		602 +8.9% 126.14 US$75,938
2025-08-14 2025-08-14 B Purchase
4.0
Jain Vivek

Chairman and CEO

Executive Director
19,551 +17.7%
112.92
US$2,207,761 		19,551 +17.7% 112.92 US$2,207,761
2025-08-14 2025-08-14 B Purchase
4.0
Jain Vivek

Chairman and CEO

Executive Director
2,378 +2.2%
112.12
US$266,613 		2,378 +2.2% 112.12 US$266,613
2025-05-30 2025-05-30 PrS Proposed sale
2.6
VIRGINIA SANZONE

Officer

Officer
700
133.62
US$93,537 		700 133.62 US$93,537
2025-05-30 2025-05-30 S Sale
2.6
Sanzone Virginia Ruth

VP, General Counsel

Officer
700 -9.9%
133.62
US$93,537 		700 -9.9% 133.62 US$93,537
2025-05-28 2025-05-28 S Sale
3.3
Voigtlander Christian B.

Chief Operating Officer

Officer
4,985 -45.0%
128.50
US$640,576 		4,985 -45.0% 128.50 US$640,576
2025-05-28 2025-05-27 S Sale
3.3
Voigtlander Christian B.

Chief Operating Officer

Officer
4,945 -47.3%
131.00
US$647,795 		4,945 -47.3% 131.00 US$647,795
2025-05-23 2025-05-23 S Sale
3.3
Voigtlander Christian B.

Chief Operating Officer

Officer
4,959 -50.3%
130.00
US$644,670 		4,959 -50.3% 130.00 US$644,670
2025-05-23 2025-05-22 S Sale
3.3
Voigtlander Christian B.

Chief Operating Officer

Officer
4,959 -53.5%
130.03
US$644,832 		4,959 -53.5% 130.03 US$644,832
2025-05-21 2025-05-21 S Sale
3.3
Voigtlander Christian B.

Chief Operating Officer

Officer
4,917 -57.0%
133.00
US$653,961 		4,917 -57.0% 133.00 US$653,961
2025-05-21 2025-05-20 S Sale
3.3
Voigtlander Christian B.

Chief Operating Officer

Officer
4,871 -61.3%
137.11
US$667,879 		4,871 -61.3% 137.11 US$667,879
2025-05-20 2025-05-19 S Sale
3.3
FINNEY ELISHA W
Non-Executive Director
600 -15.6%
138.92
US$83,353 		600 -15.6% 138.92 US$83,353
2025-05-19 2025-05-19 PrS Proposed sale
3.3
FINNEY ELISHA W

Director

Non-Executive Director
600
138.92
US$83,353 		600 138.92 US$83,353
2025-05-19 2025-05-19 S Sale
3.3
Voigtlander Christian B.

Chief Operating Officer

Officer
5,555 -69.9%
138.00
US$766,614 		5,555 -69.9% 138.00 US$766,614
2025-05-19 2025-05-16 S Sale
3.3
Voigtlander Christian B.

Chief Operating Officer

Officer
5,555 -69.9%
140.00
US$777,700 		5,555 -69.9% 140.00 US$777,700
2025-05-15 2025-05-15 PrS Proposed sale
2.1
Sousa Ben

Officer

Officer
2,000
137.36
US$274,714 		2,000 137.36 US$274,714
2025-05-15 2025-05-15 S Sale
2.1
Sousa Ben

Chief Information Officer

Officer
2,000 -80.7%
137.36
US$274,714 		2,000 -80.7% 137.36 US$274,714
2025-05-15 2025-05-15 S Sale
3.3
Voigtlander Christian B.

Chief Operating Officer

Officer
5,555 -69.9%
135.55
US$752,977 		5,555 -69.9% 135.55 US$752,977
2025-05-15 2025-05-14 S Sale
3.3
Voigtlander Christian B.

Chief Operating Officer

Officer
5,556 -69.9%
138.65
US$770,324 		5,556 -69.9% 138.65 US$770,324
2025-05-14 2025-05-14 PrS Proposed sale
3.3
Voigtlander Christian B.

Officer

Officer
55,556
138.65
US$7,702,684 		55,556 138.65 US$7,702,684
2025-05-13 2025-05-13 PrS Proposed sale
2.2
Greenberg David C.

Director

Non-Executive Director
1,942
143.66
US$278,992 		1,942 143.66 US$278,992
2025-05-13 2025-05-13 S Sale
2.2
Greenberg David C.
Non-Executive Director
1,942 -22.3%
143.66
US$278,992 		1,942 -22.3% 143.66 US$278,992
2025-01-02 2025-01-02 PrS Proposed sale
4.0
VIVEK JAIN

Officer; Director

Executive Director
1,373
155.48
US$213,474 		1,373 155.48 US$213,474
2025-01-02 2025-01-02 PlS Planned sale
4.0
Jain Vivek

Chairman and CEO

Executive Director
1,373 -1.3%
155.48
US$213,474 		1,373 -1.3% 155.48 US$213,474
2024-12-06 2024-12-06 PrS Proposed sale
2.9
Woolson Daniel

Officer

Officer
2,241
156.25
US$350,158 		2,241 156.25 US$350,158
2024-12-06 2024-12-06 S Sale
2.9
Woolson Daniel

VP, GM-Infusion Capital

Officer
2,241 -17.1%
156.25
US$350,158 		2,241 -17.1% 156.25 US$350,158
2024-12-02 2024-12-02 PrS Proposed sale
4.0
VIVEK JAIN

Officer; Director

Executive Director
12,000
162.91
US$1,954,933 		12,000 162.91 US$1,954,933
2024-12-02 2024-12-02 PlS Planned sale
4.0
Jain Vivek

Chairman and CEO

Executive Director
78 -0.1%
163.96
US$12,789 		78 -0.1% 163.96 US$12,789
2024-12-02 2024-12-02 PlS Planned sale
4.0
Jain Vivek

Chairman and CEO

Executive Director
8,250 -7.3%
163.18
US$1,346,223 		8,250 -7.3% 163.18 US$1,346,223
2024-12-02 2024-12-02 PlS Planned sale
4.0
Jain Vivek

Chairman and CEO

Executive Director
3,672 -3.1%
162.29
US$595,923 		3,672 -3.1% 162.29 US$595,923
2024-11-27 2024-11-27 PrS Proposed sale
2.2
Greenberg David C.

Director

Non-Executive Director
972
158.11
US$153,683 		972 158.11 US$153,683
2024-11-27 2024-11-27 S Sale
2.2
Greenberg David C.
Non-Executive Director
972 -16.2%
158.11
US$153,683 		972 -16.2% 158.11 US$153,683
2024-11-27 2024-11-27 S Sale
3.3
Voigtlander Christian B.

Chief Operating Officer

Officer
1,430 -100.0%
158.00
US$225,936 		1,430 -100.0% 158.00 US$225,936
2024-11-26 2024-11-26 S Sale
3.3
Voigtlander Christian B.

Chief Operating Officer

Officer
206 -100.0%
160.09
US$32,979 		206 -100.0% 160.09 US$32,979
2024-11-26 2024-11-26 S Sale
3.3
Voigtlander Christian B.

Chief Operating Officer

Officer
7,513 -97.3%
159.09
US$1,195,212 		7,513 -97.3% 159.09 US$1,195,212
2024-11-26 2024-11-25 S Sale
3.3
Voigtlander Christian B.

Chief Operating Officer

Officer
1,962 -100.0%
169.08
US$331,726 		1,962 -100.0% 169.08 US$331,726
2024-11-25 2024-11-25 PrS Proposed sale
3.3
Voigtlander Christian B.

Officer

Officer
11,111
171.00
US$1,899,981 		11,111 171.00 US$1,899,981
2024-11-04 2024-11-01 PlS Planned sale
4.0
Jain Vivek

Chairman and CEO

Executive Director
1,239 -1.2%
173.60
US$215,087 		1,239 -1.2% 173.60 US$215,087
2024-11-04 2024-11-01 PlS Planned sale
4.0
Jain Vivek

Chairman and CEO

Executive Director
2,386 -2.2%
172.76
US$412,212 		2,386 -2.2% 172.76 US$412,212
2024-11-04 2024-11-01 PlS Planned sale
4.0
Jain Vivek

Chairman and CEO

Executive Director
4,147 -3.7%
171.91
US$712,905 		4,147 -3.7% 171.91 US$712,905
2024-11-04 2024-11-01 PlS Planned sale
4.0
Jain Vivek

Chairman and CEO

Executive Director
4,228 -3.6%
170.75
US$721,933 		4,228 -3.6% 170.75 US$721,933
2024-11-01 2024-11-01 PrS Proposed sale
4.0
VIVEK JAIN

Officer; Director

Executive Director
12,000
171.84
US$2,062,135 		12,000 171.84 US$2,062,135
2024-10-01 2024-10-01 PrS Proposed sale
4.0
VIVEK JAIN

Officer; Director

Executive Director
12,000
178.46
US$2,141,579 		12,000 178.46 US$2,141,579
2024-10-01 2024-10-01 PlS Planned sale
4.0
Jain Vivek

Chairman and CEO

Executive Director
788 -0.7%
180.48
US$142,219 		788 -0.7% 180.48 US$142,219
2024-10-01 2024-10-01 PlS Planned sale
4.0
Jain Vivek

Chairman and CEO

Executive Director
3,375 -3.1%
179.16
US$604,658 		3,375 -3.1% 179.16 US$604,658
2024-10-01 2024-10-01 PlS Planned sale
4.0
Jain Vivek

Chairman and CEO

Executive Director
3,681 -3.3%
178.49
US$657,021 		3,681 -3.3% 178.49 US$657,021
2024-10-01 2024-10-01 PlS Planned sale
4.0
Jain Vivek

Chairman and CEO

Executive Director
4,156 -3.6%
177.50
US$737,682 		4,156 -3.6% 177.50 US$737,682
2024-09-03 2024-09-03 PrS Proposed sale
4.0
VIVEK JAIN

Officer; Director

Executive Director
12,000
163.46
US$1,961,539 		12,000 163.46 US$1,961,539
2024-09-03 2024-09-03 PlS Planned sale
4.0
Jain Vivek

Chairman and CEO

Executive Director
3,805 -3.5%
164.07
US$624,298 		3,805 -3.5% 164.07 US$624,298
2024-09-03 2024-09-03 PlS Planned sale
4.0
Jain Vivek

Chairman and CEO

Executive Director
4,440 -4.1%
163.59
US$726,326 		4,440 -4.1% 163.59 US$726,326
2024-09-03 2024-09-03 PlS Planned sale
4.0
Jain Vivek

Chairman and CEO

Executive Director
3,755 -3.5%
162.69
US$610,916 		3,755 -3.5% 162.69 US$610,916
2024-08-30 2024-08-30 PrS Proposed sale
2.9
Woolson Daniel

Officer

Officer
2,502
163.99
US$410,303 		2,502 163.99 US$410,303
2024-08-30 2024-08-30 S Sale
2.9
Woolson Daniel

VP, GM-Infusion Capital

Officer
2,502 -16.0%
163.22
US$408,370 		2,502 -16.0% 163.22 US$408,370
2024-08-16 2024-08-16 PrS Proposed sale
4.0
VIVEK JAIN

Officer; Director

Executive Director
12,000
156.04
US$1,872,480 		12,000 156.04 US$1,872,480
2024-08-16 2024-08-16 PlS Planned sale
4.0
Jain Vivek

Chairman and CEO

Executive Director
12,000 -10.3%
156.04
US$1,872,480 		12,000 -10.3% 156.04 US$1,872,480
2024-08-13 2024-08-13 PrS Proposed sale
2.0
Smiths Group International Holdings Ltd

Other
415,771
143.90
US$59,829,447 		415,771 143.90 US$59,829,447
2024-08-08 2024-08-08 PrS Proposed sale
2.6
VIRGINIA SANZONE

Officer

Officer
2,050
144.11
US$295,426 		2,050 144.11 US$295,426
2024-08-08 2024-08-08 PlS Planned sale
2.6
Sanzone Virginia Ruth

VP, General Counsel

Officer
2,050 -31.4%
144.11
US$295,426 		2,050 -31.4% 144.11 US$295,426
Explore more

More insider trading research around ICU Medical Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Equipment & Supplies companies with insider activity
Insider trading in North America